369 related articles for article (PubMed ID: 15168196)
1. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Meerbach A; Friedrichs C; Thust R; Wutzler P
Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
[TBL] [Abstract][Full Text] [Related]
2. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
3. Cyno-EBV (EBV-related herpesvirus from cynomolgus macaques) induces rabbit malignant lymphomas and their tumor cell lines frequently show specific chromosomal abnormalities.
Hayashi K; Chen HL; Yanai H; Koirala TR; Ohara N; Teramoto N; Oka T; Yoshino T; Takahashi K; Miyamoto K; Fujimoto K; Yoshikawa Y; Akagi T
Lab Invest; 1999 Jul; 79(7):823-35. PubMed ID: 10418823
[TBL] [Abstract][Full Text] [Related]
4. Malignant lymphomas induced by an Epstein-Barr virus-related herpesvirus from Macaca arctoides--a rabbit model.
Wutzler P; Meerbach A; Färber I; Wolf H; Scheibner K
Arch Virol; 1995; 140(11):1979-95. PubMed ID: 7503696
[TBL] [Abstract][Full Text] [Related]
5. Macaca arctoides gammaherpesvirus 1 (strain herpesvirus Macaca arctoides): virus sequence, phylogeny and characterisation of virus-transformed macaque and rabbit cell lines.
Krumbholz A; Roempke J; Liehr T; Groth M; Meerbach A; Schacke M; Maschkowitz G; Fickenscher H; Klapper W; Sauerbrei A; Wutzler P; Zell R
Med Microbiol Immunol; 2019 Feb; 208(1):109-129. PubMed ID: 30291474
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a B-lymphoblastoid cell line infected with Epstein-Barr-related virus from a cynomolgus monkey (Macaca fascicularis).
Fujimoto K; Terato K; Miyamoto J; Ishiko H; Fujisaki M; Cho F; Honjo S
J Med Primatol; 1990; 19(1):21-30. PubMed ID: 2160013
[TBL] [Abstract][Full Text] [Related]
7. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
Takimoto T; Sato H; Ogura H; Glaser R
Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
[TBL] [Abstract][Full Text] [Related]
8. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines.
Jeon JP; Shim SM; Nam HY; Baik SY; Kim JW; Han BG
Cancer Genet Cytogenet; 2007 Mar; 173(2):122-30. PubMed ID: 17321327
[TBL] [Abstract][Full Text] [Related]
9. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
10. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
Guan M; Romano G; Henderson EE
Anticancer Res; 1999; 19(4B):3007-17. PubMed ID: 10652585
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage.
Lan K; Verma SC; Murakami M; Bajaj B; Robertson ES
Curr Protoc Microbiol; 2007 Aug; Chapter 14():Unit 14E.2. PubMed ID: 18770612
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
14. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Epstein-Barr virus derived from a nasopharyngeal carcinoma that has transforming and lytic properties.
Sato H; Takimoto T; Ogura H; Tanaka J; Hatano M; Glaser R
J Natl Cancer Inst; 1986 Jun; 76(6):1019-24. PubMed ID: 3012175
[TBL] [Abstract][Full Text] [Related]
16. Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection.
Alfieri C; Ghibu F; Joncas JH
Can Med Assoc J; 1984 Nov; 131(10):1249-52. PubMed ID: 6093976
[TBL] [Abstract][Full Text] [Related]
17. Critical role of Epstein-Barr Virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation.
Yajima M; Kanda T; Takada K
J Virol; 2005 Apr; 79(7):4298-307. PubMed ID: 15767430
[TBL] [Abstract][Full Text] [Related]
18. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
[TBL] [Abstract][Full Text] [Related]
19. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV.
Ishida T; Yamamoto K
J Med Primatol; 1987; 16(6):359-71. PubMed ID: 2828628
[TBL] [Abstract][Full Text] [Related]
20. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
